Accretion Pharmaceuticals Limited (NSE:ACCPL)
India · Delayed Price · Currency is INR 143.00
+0.10 (0.07%)
At close: Jun 16, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 1.59 billion as of June 17, 2026.
Market Cap
1.59B
Enterprise Value
1.67B
Revenue
898.18M
Ranking
n/a
PE Ratio
15.84
Stock Price
143.00
Market Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has increased from 922.07M to 1.59B, an increase of 72.39%. That is a compound annual growth rate of 66.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 1.59B | 62.78% |
| Dec 31, 2025 | 976.54M | 5.91% |
| May 21, 2025 | 922.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanjivani Paranteral | 1.81B |
| Coral Laboratories | 1.79B |
| Speciality Medicines | 1.77B |
| Oxygenta Pharmaceutical | 1.77B |
| Bio Medica Laboratories | 1.70B |
| Parnax Lab | 1.49B |
| Bilcare | 1.41B |
| Aayush Wellness | 1.41B |